Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BY 4.0Organic & Biomolecular Chemistry

From serendipitous reaction discovery to antimycobacterial opportunities: general access to scarcely reported 2-((pyrrolin-5-yl)amino)phenols

Abstract

A crystallographic fragment screening unveiled a previously undetected isomerisation that opened access to a scarcely explored ligand chemotype.

Related

  1. Structure-Based Drug Discovery for Invasive Lobular Carcinoma: Druggable Targets and Translational Opportunities
    Vincent A. Obakachi, Evans E. Ojo
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  2. Pharmacokinetics and safety of TBAJ-587, a novel antimycobacterial diarylquinoline, in healthy participants
    Jerry Nedelman, Almari Conradie, Antonio Lombardi +10
    Antimicrobial Agents and ChemotherapyPeer-reviewedCC BY 4.0Full text1 citedPharmacology & toxicologyPMC
  3. Synergistic antimycobacterial activity of Piper longum and Cressa cretica extracts and their effects on the expression of rpoB, gyrA and gyrB genes in Mycobacterium tuberculosis.
    Vaibhav Kumar Tamrakar, Jyothi Bhat, Nitish Singh Parihar +1
    Medicine internationalPeer-reviewedCC BYFull textInfectious diseaseEurope PMCPMC
  4. Treating diagnostic frameworks as information systems: normative implications and opportunities
    Philip Millroth
    Translational PsychiatryPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossref
  5. Therapy-Induced Senescence in Cancer Treatment Resistance: Mechanisms, Evidence, and Translational Opportunities
    Jose-Ramon Blanco, Amancio Carnero
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{faudel2026from,
  title = {{From serendipitous reaction discovery to antimycobacterial opportunities: general access to scarcely reported 2-((pyrrolin-5-yl)amino)phenols}},
  author = {Dylan El Faudel and Gabriel Publicola and Chantal Carayon and Frédéric Robert and Caroline Toppan and Judith Alric and Coralie Carivenc and Lionel Mourey and Virginie Nahoum and Stéphanie Ballereau and Laurent Maveyraud and Yves Génisson},
  journal = {Organic \& Biomolecular Chemistry},
  year = {2026},
  month = sep,
  doi = {10.1039/d6ob01100d},
  url = {https://hal.science/hal-05763254v1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - From serendipitous reaction discovery to antimycobacterial opportunities: general access to scarcely reported 2-((pyrrolin-5-yl)amino)phenols
AU  - Dylan El Faudel
AU  - Gabriel Publicola
AU  - Chantal Carayon
AU  - Frédéric Robert
AU  - Caroline Toppan
AU  - Judith Alric
AU  - Coralie Carivenc
AU  - Lionel Mourey
AU  - Virginie Nahoum
AU  - Stéphanie Ballereau
AU  - Laurent Maveyraud
AU  - Yves Génisson
PY  - 2026
DA  - 2026/09/28
JO  - Organic & Biomolecular Chemistry
DO  - 10.1039/d6ob01100d
UR  - https://hal.science/hal-05763254v1
AB  - A crystallographic fragment screening unveiled a previously undetected isomerisation that opened access to a scarcely explored ligand chemotype.
SN  - 1477-0520
SN  - 1477-0539
ER  -